Inventor
Herman Waldmann
Inventor
Oxford, GB
Overview
Patents· 32 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
C07KPeptides27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C12NMicroorganisms or enzymes9%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture4%
PatentTitleYear
10,906,976Induction of immunotolerance to improve acceptance of tissue derived from pluripotent stem cells202110,800,850Therapeutic antibodies2020RE046877Altered antibodies and their preparation20188,921,104'Method for producing dendritic cells'20148,440,190'Antibody variants'2013RE043898'Altered antibodies and their preparation'20138,232,100'Method for producing dendritic cells'20127,993,641'Methods of treatment using anti-CD3 antibodies'20117,994,289'Humanized anti-CD3 antibodies'20117,947,272'Compositions and methods of tolerizing a primate to an antigen'20117,781,213'Method for producing dendritic cells'20107,541,443'Anti-CD4 antibodies'20097,473,556'Method for producing dendritic cells'20097,465,790'Therapeutic antibodies'20087,247,480'Method for producing dendritic cells'20077,098,006'Chimeric antibody, pharmaceutical composition and process of its production'20066,767,996'Altered antibodies and their preparation'20046,706,265'Humanized anti-CD3 specific antibodies'20046,689,869'Labeled humanized anti-CD18 antibodies and fragments and kits comprising same'20046,569,430'Antibodies to the antigen Campath-1'20036,120,766'CDW52-specific antibody for treatment of multiple sclerosis'20006,056,956'Non-depleting anti-CD4 monoclonal antibodies and tolerance induction'20005,997,867'Method of using humanized antibody against CD18'19995,985,279'Humanized antibody against CD18'19995,968,509'Antibodies with binding affinity for the CD3 antigen'19995,846,534'Antibodies to the antigen campath-1'19985,786,176'Recombinant CDw52 antigen'19985,690,933'Monoclonal antibodies for inducing tolerance'19975,670,150'Non-depleting CD4-specific monoclonal antibodies for the treatment of insulin-dependent diabetes mellitus (IDDM)'19975,585,097'Humanized anti-CD3 specific antibodies'19965,502,167'CDR grafted humanised chimeric T-cell antibodies'19964,841,025'Antibody preparations'1989Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1989–2006Based in Cambridge, GB· patent location history
1996–1998Patents assigned to BRITISH TECH GROUP (3)· patent assignee history
1997–2004Patents assigned to GLAXO WELLCOME INC (3)· patent assignee history
1998–2021Based in Oxford, GB· patent location history
1999–2018Patents assigned to BTG INT LTD (6)· patent assignee history
2004Based in Oxfordshire, GB· patent location history
2007–2014Patents assigned to ISIS INNOVATION (8)· patent assignee history
2012–2014Patents assigned to WALDMANN HERMAN (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ISIS INNOVATION | 8 | 2007–2014 |
| BTG INT LTD | 6 | 1999–2018 |
| WALDMANN HERMANself | 4 | 2012–2014 |
| BRITISH TECH GROUP | 3 | 1996–1998 |
| GLAXO WELLCOME INC | 3 | 1997–2004 |
Locations
| Location | Patents | Span |
|---|---|---|
| Oxford, GB | 18 | 1998–2021 |
| Cambridge, GB | 13 | 1989–2006 |
| Oxfordshire, GB | 1 | 2004 |